Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation

Area of Science:

• Interventional Oncology
• Hepatocellular Carcinoma Management
• Medical Imaging in Oncology

Background:

• Hepatocellular carcinoma (HCC) treatment has advanced significantly due to technological innovations.
• Image-guided therapies offer minimally invasive solutions for complex HCC cases.
• Interventional oncology is rapidly evolving, integrating new techniques into clinical practice.

Purpose of the Study:

• To review recent innovations and clinical trials in image-guided therapies for HCC.
• To evaluate advancements in intraprocedural imaging and tumor response assessment.
• To provide an outlook on emerging technologies and combination therapies in HCC treatment.

Main Methods:

• Comprehensive review of completed and ongoing clinical trials.
• Synopsis of innovations in intraprocedural imaging and tumor response assessment.
• Discussion of novel technologies like radiopaque embolic materials and combination therapies.

Main Results:

• Established image-guided therapies (TACE, RFA) are integrated into clinical practice.
• Ongoing research explores new technologies and combination treatments (locoregional + systemic agents).
• Significant advances in understanding immune response pathways related to locoregional therapies.

Conclusions:

• Interventional oncology is becoming the fourth pillar of cancer care, alongside surgery, medical, and radiation oncology.
• New developments in image guidance, therapies, and understanding of systemic effects are crucial for future HCC treatment.
• Continued research and integration of these advancements will further enhance patient outcomes.